Investors should stick to the ‘late cycle playbook' and buy these sectors, says Morgan Stanley's Mike WilsonMarket Watch • 09/18/23
Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX™ Pro Left Atrial Appendage Closure DevicePRNewsWire • 09/06/23
Boston Scientific Announces 2023 Investor Day Meeting and Conference Call Discussing Third Quarter 2023 ResultsPRNewsWire • 09/05/23
Boston Scientific shares propel higher on positive atrial fibrillation trial resultsProactive Investors • 08/28/23
Boston Scientific Surges As It Looks To Enter A Market Worth Nearly $8 BillionInvestors Business Daily • 08/28/23
ADVENT Study of the FARAPULSE™ Pulsed Field Ablation System Meets Primary Efficacy and Safety EndpointsPRNewsWire • 08/27/23
Boston Scientific reports 2Q earnings beat on rising MedSurg and Cardiovascular salesProactive Investors • 07/27/23
BSX Stock Near Buy Point: Boston Scientific Earnings Beat; Medical Giant Raises GuidanceInvestors Business Daily • 07/27/23
Boston Scientific stock gets a boost from profit and sales beats, raised outloookMarket Watch • 07/27/23